Researchers validated a novel wearable ultrasound blood pressure (BP) sensor, confirming its accuracy and safety across ...

Vaxxas, a clinical-stage biotechnology company, has expanded its global intellectual property portfolio to 42 patents, supporting its exclusive claim ...